ArticleMedicina (Kaunas, Lithuania)2025

LASSO-Driven Selection of Biochemical and Clinical Markers for Primary Resistance to PD-1 Inhibitors in Metastatic Melanoma.

Haydar C Yuksel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.